Prebiotics, Probiotics, Postbiotics & Synbiotics

SPREBIOTICS

Page Code Product Name Standardization Functionality
19 1944 Turmeric Starch (1) New
(Curcuma Longa)
Starmeric®
40% Total Starch
20% Resistant Starch
Anti-inflammatory support
Gut Health
Prebiotic
19 0565 Fenugreek Fibers
(Trigonella foenum-graecum)
FenuFibers®
50% Total Dietary Fiber
15% Protein
2.5% Steroidal Saponins
Blood sugar support
Cholesterol support
Glycemic index support
Support heart health
19 0570 Fenugreek Extract
(Trigonella foenum-graecum)
Fenumannans®
60% Galactomannan Blood sugar support
Digestive support

SPROBIOTICS

Page Code Product Name Standardization Functionality
20 1205 Bacillus coagulans (MTCC 5856) (1,2,3) New
(Bacillus coagulans)
LactoSpore®
GRAS AFFIRMED
6 Billion Organisms/g Digestive support
Gastrointestinal health
General health
20 1200 Bacillus coagulans (MTCC 5856) (1,2,3) New
(Bacillus coagulans)
LactoSpore®
GRAS AFFIRMED
15 Billion Organisms/g Digestive support
Gastrointestinal health
General health
20 1201 Bacillus coagulans (MTCC 5856) (1,2,3) New
(Bacillus coagulans)
LactoSpore®
GRAS AFFIRMED
100 Billion Organisms/g Digestive support
Gastrointestinal health
General health

SPOSTBIOTICS

Page Code Product Name Standardization Functionality
20 909 ImmunoSpore™ New
(Bacillus coagulans MTCC 5856)
15 Billion spores/g count before heat inactivation
1,000 spores/g count after heat inactivation
Immune support

SSYNBIOTICS

Page Code Product Name Standardization Functionality
20 1206 LactoWise® 15 Billion Organisms/g
45% Galactomannan
5% Protein
Digestive support
Gastrointestinal health
General health
20 1101 LactoCran® (3) New 2 Billion Organisms/g
Organic Cranberry Seed/Juice
Digestive support
Gastrointestinal health
General health
Healthy Urinary Tract Support

SPATENTS

(1) LactoSpore® + Turmeric Starch (Starmeric® )

US 10,323,227: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof

(2) LactoSpore®

US 9,579,352: Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans

US 10,166,261: Bacillus coagulans MTCC 5856 for the management of major depressive disorder

US 10,260,112: Novel PCR Primers and methods thereof for the Identification of Bacillus coagulans MTCC 5856

US 10,293,008; US 9,717,766; AU2015308650; EA034017; MX376004; ZL201580042813.X: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof

EP3240553, KR10-2157043: Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856

US 10,792,295: Composition for management of Helicobacter pylori infection

US 10,806,760: Compositions and methods for reducing flatulence

(3) LactoCran®

US 9,717,766: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof

Disclaimer

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

    VISIT US

  • Edifício Koerich Beiramar Office
    Avenida Mauro Ramos
    1970- Sala 705-Centro
    Florianópolis-SC
    Brasil CEP 88.020-302

  • +55 48 3206 3682
  • info@sabinsa.com.br

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.